Clinical Trial Update: Effects of Dehydroepiandrosterone Supplementation on Cumulus Cells Gene Expression Under Controlled Ovarian Hyper-stimulation in Patients With Diminished Ovarian Reserve [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated dehydroepiandrosterone (DHEA) supplementation on cumulus cell gene expression in women with diminished ovarian reserve underg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diminished Ovarian Reserve
• Infertility

Drugs mentioned

• Dehydroepiandrosterone (dehydroepiandrosterone)

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Dehydroepiandrosterone, DHEAS | Phase 3 | Status: COMPLETED